Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Steve who wrote (254)	11/20/1998 1:38:00 PM
From: Dr. Bob	Read Replies (1) \| Respond to of 496

Steve, Just to let you know I'm one guy still in the stock. I take it most of that post was to ventilate, but I'll respond to a couple points: If the stock doesn't move in a bull market - it has not been a bull market for biotechs for years - your point could be made about nearly all the biotechs. Sooner or later, they're going to move, and GLFD will be one of the movers, IMO. Exercise some foresight and sell the company - how is that foresight? That's a short term solution so that an investor like yourself can break even. For a company with several potential blockbuster drugs, that doesn't sound like foresight, it sounds like short sight. What will it take to get this stock moving? More progress on their promising drugs, an announcement of a breakthrough approach to one of several illnesses they're working on, a buyout offer, increased interest in biotechs as a sector - the potential triggers are numerous. Bob